The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
By 2030, What Market Size Is The Perjeta (Pertuzumab) Market Expected To Reach Based On Its 2026 Value?
The market for perjeta (pertuzumab) has experienced rapid expansion in recent years. This market is set to increase from $1.08 million in 2025 to $1.26 million in 2026, achieving a compound annual growth rate (CAGR) of 15.7%. The growth observed in the past can be attributed to the approval of HER2 monoclonal antibodies, the rising occurrence of breast cancer, developments in HER2 diagnostics, robust clinical trial findings, and its inclusion in oncology guidelines.
The market size for perjeta (pertuzumab) is expected to experience significant growth in the coming years. It is projected to reach $2.23 million by 2030, exhibiting a compound annual growth rate (CAGR) of 15.4%. The anticipated expansion during the forecast period can be attributed to factors such as the growth of her2 positive patient identification, expansion into adjuvant therapy settings, increased combination regimen adoption, rising oncology drug spending, and global market penetration. Prominent trends for the forecast period include the expansion of her2 targeted combination therapies, growing use in early and metastatic breast cancer, rising adoption of dual her2 blockade, an increased focus on precision oncology, and improved survival outcomes in her2 positive patients.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19917&type=smp
Which Key Drivers Are Affecting The Perjeta (Pertuzumab) Market Development?
The increasing occurrence of breast cancer is anticipated to boost the expansion of the Perjeta (pertuzumab) market in the future. Breast cancer is defined as a condition where abnormal cells form within the breast tissue, frequently starting in the ducts or lobules. This increase in breast cancer cases stems from shifts in lifestyle, such as higher rates of obesity and inactivity, alongside enhanced early diagnosis facilitated by extensive screening initiatives. Perjeta (pertuzumab) serves as a treatment for HER2-positive breast cancer, functioning by targeting the HER2 receptor; it is commonly administered alongside trastuzumab and chemotherapy to enhance therapeutic results. As an illustration, data from October 2023, provided by Ray of Light Wales, a UK-based non-profit organization, indicates that approximately 600,000 individuals are living in the UK following a breast cancer diagnosis, a figure expected to reach 1.2 million by 2030. Consequently, the growing prevalence of breast cancer is fueling the expansion of the herceptin biosimilars market.
How Is The Perjeta (Pertuzumab) Market Organized By Segment Classification?
The perjeta (pertuzumab) market covered in this report is segmented –
1) By Source: Human source, Animal source
2) By Product: Monoclonal Antibody, Biologic Drug
3) By Indication: Early Breast Cancer, Metastatic Breast Cancer
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
What Trends Are Influencing The Evolution Of The Perjeta (Pertuzumab) Market?
A prominent trend in the Perjeta (pertuzumab) market centers on developing technologically advanced solutions, particularly subcutaneous combination therapies, to enhance patient outcomes and improve treatment convenience. Subcutaneous combination therapies refer to treatment methods where multiple drugs are delivered together in a single injection under the skin to address a specific condition. For example, in November 2023, Chugai Pharmaceutical Co., Ltd., a Japan-based pharmaceutical company, launched Phesgo, a subcutaneous combination treatment for HER2-positive breast cancer and advanced or recurrent HER2-positive colorectal cancer. This innovative treatment for subcutaneous administration integrates the monoclonal antibodies pertuzumab and trastuzumab with vorhyaluronidase alfa, enabling administration in a mere 5 to 8 minutes, which significantly shortens the time compared to traditional intravenous infusions. Phesgo is indicated for patients with advanced or recurrent HER2-positive colorectal cancer and represents the first subcutaneous option available for this condition.
Who Are The Industry Participants Involved In The Perjeta (Pertuzumab) Market?
Major companies operating in the perjeta (pertuzumab) market are Roche Holding AG
Get The Full Perjeta (Pertuzumab) Market Report:
https://www.thebusinessresearchcompany.com/report/perjeta-pertuzumab-global-market-report
Where Is The Perjeta (Pertuzumab) Market Primarily Concentrated By Region?
North America was the largest region in the perjeta (pertuzumab) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the perjeta (pertuzumab) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Perjeta (Pertuzumab) Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/perjeta-pertuzumab-global-market-report
Browse Through More Reports Similar to the Global Perjeta (Pertuzumab) Market 2026, By The Business Research Company
Perlite Market Report 2026
https://www.thebusinessresearchcompany.com/report/perlite-global-market-report
Data Lake Market Report 2026
https://www.thebusinessresearchcompany.com/report/data-lake-global-market-report
Boat And Ship Mro Market Report 2026
https://www.thebusinessresearchcompany.com/report/boat-and-ship-mro-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model